Theravance Biopharma Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: TBPH
Share price (5/22/26): $16.37
Market cap (5/22/26): $844 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 10 pages Assignment Agreement

from 8-K 139 pages Equity Purchase and Funding Agreement by and Between Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 Icav July 13, 2022

from 8-K 35 pages Asset Purchase Agreement

from 10-12B/A 38 pages Separation and Distribution Agreement by and Between Theravance, Inc. and Theravance Biopharma, Inc. Dated as of [·], 2014